From: Pregnancy-associated cardiac dysfunction and the regulatory role of microRNAs
miRNA | Regulation in human pregnancy | Ref. | Heart disease | Mechanism and outcome | Ref. |
---|---|---|---|---|---|
miR-125b-5p | ↑ serum in first trimester, normalizes in second and third | [138] | Mouse LAD ligation | ↓ bak1, ↓ klf13 → ↓ cardiomyocyte apoptosis | [139] |
miR-183-5p | ↑ serum, first trimester ↓ serum, third trimester | [138] | Rat cardiac IRI | ↓ VDAC1 → ↓ apoptosis | [140] |
miR-200b-3p | ↑ serum, first trimester ↓ serum, third trimester | [138] | Mouse STZ-induced diabetic cardiomyopathy | ↓ CD36, ↓ EndoMT → ↓ cardiac fibrosis ↓ cardiac dysfunction | |
miR-21-3p | ↑ plasma | Mouse TAC and Ang II infusion | ↓HDAC8 expression + Akt/Gsk3β signaling→ ↓ cardiac hypertrophy | [145] | |
miR-195-5p | ↑ plasma | [146] | Mouse STZ-induced diabetic cardiomyopathy | ↓ miR-195-5p → ↑ Bcl-2, ↑ sirtuin 1 → ↓ cardiac hypertrophy, ↓ ROS, ↓ apoptosis, ↑ myocardial capillary density, ↑coronary blood flow | [147] |
Rat cardiomyocytes | ↓ miR-195-5p → ↑ SGK1 → rescues hERG potassium ion channel deficiency | [148] | |||
miR-29a | ↓ serum | [149] | Zucker diabetic fatty rats | ↓ miR-29a → ↓ mcl-1 | [150] |
Rat myocardial cells stimulated with high glucose | ↓ IGF-1 → ↑ apoptosis | [151] | |||
miR-222 | ↓ serum | [149] | Mice with diabetic cardiomyopathy | ↓ Wnt/ β-catenin signaling → ↓ EndoMT → ↓ cardiac fibrosis, ↑ cardiac function | [152] |
IRI in cardiomyocyte-specific miR-222 OE mice | ↓ p27/HIPK1/Hmbox-1 → ↑ growth/proliferation, ↓ apoptosis | [152] | |||
miR-222 OE in mice | ↓ p27 → ↑ mTOR signaling, ↓ autophagy → ↑ hypertrophy, ↑ fibrosis, ↑ dysfunction with age | [153] |